Heme Flashcards

1
Q

Iron deficiency anemia: review

A
  • Results in ineffective erythropoiesis
    • Microcytic, hypochromic anemia
    • Insufficient iron= insufficient amount of hemoglobin produced
  • In infants/small children: most common form of nutritional deficiency
  • Adults: reflects depletion of iron stores due to chronic blood loss
    • Gastrointestinal bleeds, menstruation, cancer
  • Typical Hgb 9-12 g/dL
  • Decreased serum ferritin concentration (<30 ng/mL)
  • Tx: ferrous iron salts for >1 year
  • In cases of severe anemia or severe coex conditions (i.e CAD) may postpone elective surgery for up to 4 months in order for ferrous iron salts to improve hemoglobin levels
    • If unable to delay surgery longer than 3 weeks, IV iron preparations can be considered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

vitamin B 12 deficiency: review

A
  • Essential for normal DNA synthesis results in macrocytic (large RBCs) anemia
  • Alcohol abuse, poor diet, intestinal malabsorption syndromes, long N2O exposure at high concentrations
  • Pernicious anemia
    • Hgb levels 8-10 g/dL with large RBC volume
    • Degeneration of the lateral and posterior columns of spinal cord
      • Symmetrical paresthesia, loss of proprioception and vibration in lower extremities
      • Unsteady gait, diminished deep tendon reflexes
      • Memory impairment and depression
      • Thick, large smooth tongue (airway!)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

hemolytic anemia: review

A
  • Accelerated destruction (hemolysis) of erythrocytes
    • Increased levels of unconjugated bilirubinemia
    • Increased lactate dehydrogenase (LDH) level
  • Results in tissue hypoxia and hyperproduction of RBCs in the bone marrow
    • Immature erythrocytes
  • Disorders of red cell structure
    • Hereditary spherocytosis
    • Paroxysmal nocturnal hemoglobinuria
  • Disorders of red cell metabolism
    • G6PD deficiency
    • Pyruvate kinase deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

hereditary hemolytic anemia, hereditary spherocytosis: REVIEW

A
  • Autosomal dominate, most common hereditary hemolytic anemia in US
    • Abnormal RBC membrane protein composition → cell becomes more rounded and fragile
  • Ranges from mild/clinically silentà severe with life-threatening hemolysis and anemia
  • Splenomegaly and fatigue
  • Risk of hemolytic crisis with viral/bacterial infections
  • Gallstones and jaundice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

paroxysmal nocturnal hemoglobinuria: REVIEW

A
  • Complement- activated RBC hemolysis
    • Stem cell disorder, presents during 2nd- 8th decade of life
    • Abnormalities or reduction in a RBC membrane protein
    • Life expectancy after diagnosis 10 years
    • Thought to be result of CO2 retention and subsequent acidosis
  • High risk for DVT due to complement activation
    • Hepatic and portal veins
  • Aplastic bone marrow
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

hereditary hemolytic anemia, glucose 6 phosphate dehydrogenase (G6PD) deficiency: REVIEW

A
  • Phosphogluconate oxidative metabolic pathway
    • Normally counteracts environmental oxidants and prevents globin denaturation
    • In deficiency of G6PD enzyme, oxidative stress causes denaturation of Hgb which precipitates on the inner surface of the RBC membrane resulting in membrane damage and hemolysis
  • Most common enzymatic disorder of RBCs worldwide
    • African Americans, Asians and Mediterranean populations
  • Ranges from mild/no hemolysis (Class V and IV) → chronic hemolytic anemia (Class I)
  • Oxidative drugs, infection, ingestion of fava beans aggravate preexisting hemolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

hereditary hemolytic anemia, pyruvate kinase deficiency: REVIEW

A
  • Most common enzyme defect that results in congenital hemolytic anemia
  • Worldwide
    • Northern European descent and China
  • Less prevalent than G6PD deficiency but considerably greater occurrence of chronic hemolysis
  • Accumulation of 2,3 DPG
    • Shifts oxyhemoglobin curve to the right
    • High incidence of hemolysis in the spleen → splenomegaly
    • Life-threatening, transfusion-requiring hemolytic anemia at birth
  • Chronic jaundice, gallstones
  • Splenectomy (early in life) improves degree of hemolysis and may eliminate need for transfusions → at high risk of infections
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List acquired hemolytic anemias.

A
  • Immune system induced hemolysis
    • Sensitization of RBCs (with transfusion)
    • Disease- induced
    • Drug- induced
  • Infection induced hemolysis
    • Malaria
      • Particles released during hemolysis can result in DIC and hypersplenism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Disorders of Hemoglobin Molecule,
Sickle Cell Disease: Review

A
  • Inherited homozygous disorder of the hemoglobin molecule
  • Substitution of valine for glutamic acid on the beta globulin chain
  • Results in mutant hemoglobin (S) → 70-98% Hgb is type S
  • Extreme states of deoxygenation → Hgb aggregates forming a polymer distorting the erythrocyte’s membrane → sickled cell shape
  • Cells sickle and occlude small vessels → decreasing blood flow and oxygen delivery to tissues
  • Increased incidence of hemolysis resulting in average RBC lifespan of 10-20 days (normal 120 day lifespan)
  • Oxy-hemoglobin curve shifts to the right as compensation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sickle cell disease: complications

A
  • Begins early in life, progression highly variable
  • Severe hemolytic anemia → end- organ damage
    • Bone marrow, spleen, kidneys, CNS
  • Splenic infarction → loss of splenic function within first decade of life → infection!
  • Kidney → painless hematuria and loss of concentrating ability → chronic renal failure in third-fourth decade of life
  • Pulmonary damage due to chronic persistent inflammation
  • Neurologic complications include both ischemic and hemorrhagic strokes
  • Vaso-occlusive crises
    • Episodic painful bone and joint pain associated with concurrent illness, stress, dehydration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is sickle cell crisis?

A
  • Life threatening
  • With de-oxygenation, Hgb S forms an insoluble globulin polymer
    • Acute episodic vaso-occlusive crisis
    • Ischemia / infarction of organs
    • Pain, stroke, renal failure, liver failure, splenic sequestration, PE
    • Very painful
    • Acute chest syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sickle cell crisis: What is acute chest syndrome?

A
  • Can be fatal (typically 2-3 days postop)
  • Pneumonia-like, presence of new pulmonary infiltrate involving one complete lung segment
  • Pulmonary vascular occlusion
  • Pleuritic chest pain, dyspnea, fever (>38.5 C), acute pulmonary hypertension
  • Transfusion or exchange transfusion to Hct of 30%
  • Supplemental 02, inhaled nitric oxide (reduce pulmonary hypertension)
  • Antibiotics
  • Inhaled bronchodilators
  • Aggressive pain management
  • Monitor for pain crises, stroke, and infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Disorders of Hemoglobin Molecule:
Thalassemia Major: Review

A
  • Inability to form either ⍺ (⍺-thalassemia) or β (β-thalassemia) globin chains of hemoglobin
  • Severe- life-threatening anemia, often require repeated transfusions
  • Hallmarks: ineffective erythropoiesis, hemolytic anemia and hypochromia with microcytosis
  • Chronic deficit in O2 carrying capacity → max erythropoietin release → increased unbalanced globin synthesis → aggregation and precipitate formationà membrane damage
    • Some cells destroyed in bone marrow → ineffective erythropoiesis
    • Some escape into circulation →hemolytic anemia and hypochromia with microcytosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thallasemia major: complications

A
  • Extramedullary hematopoiesis → bone marrow hyperplasia (maxillary bone and frontal bone), stunted growth and osteoporosis, hepatomegaly
  • Hemolytic anemia → splenomegaly, CHF, dyspnea and orthopnea
  • Transfusion therapy → iron overload → cirrhosis and jaundice, right sided- heart failure, endocrinopathyà chelation therapy
  • Increased risk infection (splenectomy)
  • Arrhythmias and very sensitive to digitalis
  • Spinal cord compression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Clinical sequelae of iron overload (picture)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Disorders of Hemoglobin Molecule:
Methemoglobinemia: Review

A
  • Iron moiety in Hgb is oxidized from the ferrous (Fe2+) state to ferric (Fe3+) state
  • Methemoglobinemia moves the oxyhemoglobin dissociation curve markedly to the leftlittle oxygen is delivered to the tissues
    • Results in polycythemia
  • Normal RBC maintains methemoglobin levels <1% through the methemoglobin reductase enzyme system
    • Methemoglobin levels <30%= no compromise to tissue oxygenation
    • Methemoglobin levels 30-50%= symptoms of oxygen deprivation
    • Methemoglobin levels >50%= coma and death
17
Q

In a patient with methemoglobinemia:

Pulse oximetry falsely _________ SpO2 when SaO2 is > 85%.

Pulse oximetry falsely _________ SpO2 when SaO2 is

A

Pulse oximetry falsely underestimates SpO2 when SaO2 is > 85%.

Pulse oximetry falsely overestimates SpO2 when SaO2 is

18
Q

Methemoglobinemia: Avoid toxic levels of which drugs in which populations?

A
  • Avoid toxic levels of:
    • local anesthetics (prilocaine/benzocaine)
    • nitrates
    • nitric oxide especially in infants
    • patients with Hgb M
    • those with G6PD deficiency
19
Q

Aplastic Anemia: Review

A
  • Aplastic anemia refers to bone marrow failure characterized by destruction of rapidly growing cells
    • RBC, WBC (neutrophils) and platelets
  • Marrow Damage or failure from:
    • Genetic disorders (Fanconi Anemia → pancytopenia and acute leukemia)
    • Drugs (see table 24-1 Stoelting 7th ed)
    • Radiation
    • Infectious process (viral hepatitis, Epstein-Barr virus, HIV, rubella, TB)
  • CBC/WBC/Platelet values can be extremely low
  • May need pre-op transfusion
  • Know pre-op medications and therapies
20
Q

What are drugs associated with marrow damage? (Stoelting Table 24-1)

A
  • Antibiotics (chloramphenicol, penicillin, cephalosporins, sulfonamides, amphotericin B, streptomycin
  • Antidepressants (lithium, tricyclics)
  • Antiepileptics (dilantin, carbamazepine, valproic acid, phenobarbital)
  • Anti-inflammatory drugs (phenylbutazone, nonsteroidals, salicylates, gold salts)
  • Antiarrhythmics (lidocaine, quinidine, procainamide)
  • Antithyroidal drugs (propylthiouracil)
  • Diuretics (thiazides, pyrimethamine, furosemide)
  • Antihypertensives (captopril)
  • Antiuricemics (allopurinol, colchicine)
  • Antimalarials (quinacrine, chloroquine)
  • Hypoglycemics (tolbutamide)
  • Platelet inhibitors (ticlopidine)
  • Tranquilizers (prochlorperazine, meprobamate)

**bolded are drugs we give frequently

21
Q

Hereditary Coagulation Disorder:
Hemophilia A: Review

A
  • X chromosome congenital factor VIII deficiency
    • Severe Hemophilia:
      • Factor VIII levels less than 1% of normal
      • Diagnosis as children due to frequent spontaneous hemorrhages in joints and muscles or organs
    • Moderate Hemophilia:
      • Factor VIII levels 1% to 5% of normal
      • Reduced severity of the disease
      • Increased risk bleeding with surgery/trauma
      • Less problems with joints and muscles
    • Mild Hemophilia:
      • Factor VIII levels as low as 6% to 30%
      • often undiagnosed until adulthood
      • Increased bleeding risk with major surgery
    • Significantly prolonged PTT /normal PT
22
Q

Hereditary Coagulation Disorder:
Hemophilia B: Review

A
  • Congenital factor IX deficiency
    • Severe disease
      • Factor IX levels of less than 1%
      • Associated with severe bleeding
    • Moderate disease
      • Factor IX levels of bleeding 1% to 5%
    • Mild disease
      • Factor IX levels of between 5% and 40%
  • Significantly prolonged PTT /normal PT
23
Q

Hereditary Coagulation Disorder:
von Willebrand’s Disease: Review

A
  • Most common inherited disorder of PLATELET FUNCTION
  • Problem is either a quantity or quality issue with vWF
    • Type 1: Quantitative defect; Desmopressin will work!
    • Type 2: Qualitative defect; desmopressin has varied results
    • Type 3: virtual absence of vWF because endothelium lacks vWF; desmopressin has no effect
  • Mucus membrane bleeding common and results in:
    • Epistaxis
    • Easy bruising
    • Menorrhagia
    • Gingival and gastrointestinal bleeding
    • Type 3 will also see bleeding in muscles and joints
  • Platelet count normal
  • Bleeding time is markedly prolonged (normal is 3-10minutes); rapid platelet function assay (RPFA)
  • May have prolonged PTT (due to low levels of factor VIII)
24
Q

Hereditary coagulation disoders (chart)

A
25
Q

What is the treatment of vitamin K deficiency and appropriate time frame?

A
  • non emergent tx: vitamin K
    • (6 - 24 hours prior to procedure for full effect)
  • FFP if active bleeding is present
26
Q

What are some antiplatelet drugs that your patient may come in on and what are their indications?

A
  • indicated for pts at risk for CVA, MI, other vascular thrombosis complications
    • aspirin
    • NSAIDs
    • PDE inhibitors
    • ADP receptor antagonists
27
Q

Can you do regional with:

LMWH?

ASA/NSAIDS?

Plavix?

SQ heparin?

Coumadin?

A
  • increased risk for spinal hematoma/hemorrhage
  • LMWH: +/-regional 24 hours after last dose
  • ASA/NSAIDS: regional may beok as long as no other anticoagulants
  • Plavix: NO regional (stop 7 days)
  • SQ heparin: regional may be okay (give after the regional)
  • Coumadin: stop 5 days prior (INR < 1.5)
28
Q

Describe perioperative management of heparin therapy. MOA? Labs to monitor? Reversal? Complication?

A
  • Indirectly inhibits thrombin and factor Xa by binding to AT-III
    • Monitor with PTT or ACT
    • Reversal is Protamine
    • Complication is HIT
      • (thromboembolic complications)
29
Q

Describe perioperative management of coumadin therapy. MOA? Labs to monitor? Reversal?

A
  • Competes with vit K and inhibits synthesis of vit K-dependent clotting factors
    • II, VII, IX, and X
  • Monitored with PT and INR
  • Reversal with vit K, 4-factor PCCs, FFP